2022 Year In Review

Recruiting leaders across the continuum of healthcare, we help to build the companies that are allowing people to live longer, healthier lives. Below, please find highlights of our Board and Executive Search work from 2022.

Board Advisory and Executive Recruitment

Adaptimmune Therapeutics plc - Chief Commercial Officer — Cintia Piccina (Former SVP, Global Commercial and US General Manager, 2seventy bio)

Aerium Therapeutics - Chief Medical Officer — Prakash Bhuyan, M.D., Ph.D. (Former Vice President, Clinical Development, AstraZeneca)

Agios Pharmaceuticals - Chief Financial Officer  — Cecilia Jones, (Former Chief Financial Officer, LogicBio Therapeutics)

Agios Pharmaceuticals - Board Director – Cynthia Smith (former Chief Commercial Officer, ZS Pharma, Inc.)

Agios Pharmaceuticals - Board Director – Rahul Ballal, Ph.D. (Chief Executive Officer, Imara, Inc.)

Alkermes - Board Director – Christopher Wright, M.D., Ph.D. (Chief Medical Officer, AavantiBio, Inc.)

ALX Oncology - Board Director – J. Scott Garland (Chief Executive Officer, PACT Pharma, Inc.)

Athira Pharma - Board Director – Michael Panzara, M.D. (Chief Medical Officer, Head of Therapeutics Discovery and Development, Wave Life Sciences)

Atsena Therapeutics - Chief Financial Officer and Chief Business Officer  — Elisabeth Leiderman, M.D. (Former Chief Financial Officer & Head of Corporate Development, Decibel Therapeutics)

Black Diamond Therapeutics - Director and Audit Committee Chair – Wendy Dixon, Ph.D. (Former Chief Marketing Officer and President of Global Marketing, Bristol Myers Squibb)

C4 Therapeutics - Board Director – Laura Bessen, M.D. (Managing Partner, Maxsam Advisors LLC, Former Vice President, Head of US Medical, Bristol-Myers Squibb)

C4 Therapeutics - Board Director – Donna Grogan, M.D. (Principal, Grogan Consulting, Former Chief Medical Officer, Clementia Pharmaceuticals)

C4 Therapeutics - Board Director and Audit Committee Chair – Utpal Koppikar (Chief Financial Officer, Atara Biotherapeutics, Inc.)

Catamaran Bio - Board Chair – Frank Lee (Chief Executive Officer, Forma Therapeutics)

Collegium Pharmaceutical - Board Director — Neil McFarlane (Former Chief Executive Officer and Board member, Adamas Pharmaceuticals, Inc.)

Editas Medicine - President and Chief Executive Officer — Gilmore O’Neill, M.B., M.M. Sc, (Former Executive Vice President, R&D and Chief Medical Officer, Sarepta Therapeutics)

Glympse Bio - Chief Scientific Officer — Jonathan Wilde, Ph.D. (Vice President, Discovery Research and Collaborations, Veracyte, Inc.)

HotSpot Therapeutics - Board Director– Jose “Pepe” Carmona (Chief Financial Officer, Rubius Therapeutics, Inc.)

Innovent Biologics - Board Director – Gary Zieziula (President, Kyowa Kirin USA Holdings, Inc.)

Kymera Therapeutics - Board Director — Leigh Morgan (Chief Strategy and Operating Officer, Nia Tero)

Kymera Therapeutics - Board Director — Victor Sandor, M.D. C.M. (Former Chief Medical Officer, Array BioPharma, Inc.)

Merus N.V. - Executive Vice President and Chief Commercial Officer — Shannon Campbell (Former Senior Vice President, Head US Solid Tumor Franchise, Novartis Oncology)

Nested Therapeutics - Chief Medical Officer — Philip Komarnitsky, M.D., Ph.D. (Former Vice President, Head of Translational Medicine and Early Development, Sumitomo Dainippon Pharma Oncology)

PsiOxus Therapeutics - Chief Executive Officer — Howard Davis, Ph.D. (Former Chief Operating Officer, Third Harmonic Bio)

Ribon Therapeutics - President and Chief Executive Officer — Prakash Raman, Ph.D., (Former Senior Partner, Chief Business Development Officer, Flagship Pioneering)

Roivant Sciences - Chief Medical Officer-In-Residence — Deya Corzo, M.D., (Former Executive Vice President & Chief Medical Officer, Sigilon Therapeutics)

Seagen - Executive Director, Global Product/Program Leader, Oncology Portfolio Management — Yan Gao, M.D., (Former Global Franchise Director, Oncology and Infectious Disease, Abbott)